The global neurovascular devices market is expected to showcase a considerable growth rate during the forecast period. The rising in the aging population results in the risk of the rising incidence of neurovascular disorders that include stroke. For instance, as per the Internet Stroke Center around 75% of strokes occur in people over the age of 65. Furthermore, the risk of having a stroke doubles after the age of 55. The demand for improved treatment techniques along with rising cases of neurovascular in the elderly population is contributing a considerable revenue share. For instance, the introduction of new flow diversion stent technique, the need to treat 00 aneurysms along with bypass has fallen down.
Request a Free Sample of our Report on Neurovascular Devices Market: https://www.omrglobal.com/request-sample/neurovascular-devices-market
The geriatric population aged 65 years and above is anticipated to rise. Old age is considered one of the largest risk factors for developing several diseases includes neurological conditions and cardiovascular. Thus, this factor is expected to drive the growth of the neurovascular devices market during the forecast period. According to Centers for disease control and prevention, in the US every year more than 795,000 people suffer from a stroke. Therefore, the prevalence of movement disabilities owing to stroke and its treatment with enables of embolization coils and stents in hospitals and clinical centers fuel the growth of the neurovascular devices market.
The key therapeutic area targeted by neurovascular diseases is the diagnosis and treatment of both types of strokes such as ischemic stroke and hemorrhagic stroke. Stroke majorly involves the use of neurovascular devices includes balloon catheters, flow diversion devices, guide wires, embolic coils, and stenting systems. The key market players are focusing on the collaboration that results in the investment in R&D activity and enhanced their product portfolio for the development of improved versions of diagnosis tools for advanced treatment of neurovascular diseases. For instance, in July 2017, Johnson and Johnson introduced Cerenovus, a new neurovascular business that focuses on delivering innovative therapies for stroke patients. This product approval enabled the company to enhance its product portfolio and neurovascular care along with targeted investments.
A Full Report of Neurovascular Devices Market is Available at https://www.omrglobal.com/industry-reports/neurovascular-devices-market
Global Neurovascular Devices Market- Segmentation
- Brain Aneurysm
- Cerebral Artery Stenosis
- Ischemic Strokes
- Neurothrombectomy Devices
- Cerebral Angioplasty & Stenting Devices
- Embolization Devices
- Others (Vascular Reconstruction Device)
Global Neurovascular Devices Market – Segment by Region
- Rest of Europe
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East Africa
- Acandis GmbH & Co. KG
- Asahi Intecc Co., Ltd.
- B. Braun Melsungen AG
- Balt, USA, LLC
- Boston Scientific Corp.
- Cardinal Health, Inc. (Cordis)
- Edwards Lifesciences Corp.
- InspireMD, Inc.
- Integra LifeSciences Corp.
- Intra special catheters GmbH
- Johnson & Johnson Service, Inc.
For More Customized Data, Request for Report Customization @https://www.omrglobal.com/report-customization/neurovascular-devices-market
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 780-304-0404